What To Expect From Cytek Biosciences Inc (CTKB) Q3 2024 Earnings [Yahoo! Finance]
Cytek Biosciences, Inc. (CTKB)
Company Research
Source: Yahoo! Finance
The consensus estimate for Q3 2024 revenue is $50.70 million, and the earnings are expected to come in at -$0.02 per share. The full year 2024's revenue is expected to be $203.94 million and the earnings are expected to be -$0.09 per share. More detailed estimate data can be found on the Forecast page Warning! GuruFocus has detected 1 Warning Sign with CTKB. Revenue estimates for Cytek Biosciences Inc ( NASDAQ:CTKB ) have declined from $208.80 million to $203.94 million for the full year 2024 and from $247.48 million to $235.32 million for 2025 over the past 90 days. Earnings estimates for Cytek Biosciences Inc ( NASDAQ:CTKB ) have increased from -$0.10 per share to -$0.09 per share for the full year 2024 and from -$0.02 per share to $0.02 per share for 2025 over the past 90 days. In the previous quarter of 2024-06-30, Cytek Biosciences Inc's ( NASDAQ:CTKB ) actual revenue was $46.62 million, which missed analysts' revenue expectations of $49.53 million by -5.87%. Cytek Bioscien
Show less
Read more
Impact Snapshot
Event Time:
CTKB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CTKB alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CTKB alerts
High impacting Cytek Biosciences, Inc. news events
Weekly update
A roundup of the hottest topics
CTKB
News
- Cytek Biosciences to participate in the Piper Sandler 36th Annual Healthcare ConferenceGlobeNewswire
- Cytek® Biosciences Named “Overall BioTech Company of the Year” in 2024 BioTech Breakthrough Awards ProgramGlobeNewswire
- Cytek Biosciences, Inc. (NASDAQ: CTKB) had its price target raised by analysts at Piper Sandler from $8.00 to $8.50. They now have an "overweight" rating on the stock.MarketBeat
- Cytek® Biosciences Becomes First Company to Add Ability to Detect Subcellular Particles to Its Cell SorterGlobeNewswire
- Cytek Biosciences Third Quarter 2024 Earnings: Beats Expectations [Yahoo! Finance]Yahoo! Finance
CTKB
Earnings
- 11/5/24 - Beat
CTKB
Sec Filings
- 11/20/24 - Form 4
- 11/20/24 - Form 4
- 11/20/24 - Form 4
- CTKB's page on the SEC website